President Trump’s missile defense project, called the “Golden Dome for America,” aims to protect the U.S. from foreign threats. But it has been criticized by China as threatening to increase the risks of militarizing space and a global arms race. The president on Tuesday said his administration had “selected an architecture” for the “state-of-the-art system,”
Cuban American leaders have called for the release of political prisoners and the fall of communist rule. A group of Cuban American members of Congress and U.S. Secretary of State Marco Rubio have called for Cuba’s freedom and the release of more than 1,000 political prisoners as part of a commemoration of the archipelago’s Independence
The new U.S. ambassador to Mexico, Ronald Johnson—a former CIA official for more than 20 years and former Green Beret in the U.S. Army Special Forces—arrived in Mexico this week for his first meeting with Mexican President Claudia Sheinbaum. Johnson, who was President Donald Trump’s U.S. ambassador to El Salvador from 2019 to 2021, presented
In January, the Department of Defense designated several companies, including CATL, as Chinese military companies. Lawmakers with the House Select Committee on the Chinese Communist Party on May 20 criticized American banks for backing a blacklisted Chinese battery maker, suggesting legislation was needed to explicitly prohibit this. China’s Contemporary Amperex Technology Co. (CATL) went public
President Trump has said the U.S. could step away from Russia-Ukraine peace talks if they prove futile. VP Vance took it a step further by saying the U.S. is totally open to doing so.
Differences between President Trump and South African President Cyril Ramaphosa came to a head Wednesday afternoon in a tense exchange in the Oval Office, as Mr. Trump confronted him over whether White genocide is taking place in South Africa. Mr. Trump and Rampahosa met for a critical conversation — with South African-born billionaire Elon Musk
The agency is challenging more than 200 patent listings it says were improperly used to keep prescription prices high. The Federal Trade Commission on May 21 escalated its efforts to lower prescription drug costs, renewing challenges to more than 200 patents it says were improperly listed to prevent generic versions of brand-name drugs from reaching